Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke | Zendy

Patompong Ungprasert | Zendy; Eric L. Matteson | Zendy; Charat Thongprayoon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke

Author(s) -

Patompong Ungprasert,

Eric L. Matteson,

Charat Thongprayoon

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.011678

Subject(s) - medicine , meloxicam , diclofenac , relative risk , odds ratio , stroke (engine) , hazard ratio , confidence interval , rofecoxib , meta analysis , nimesulide , incidence (geometry) , lower risk , anesthesia , cyclooxygenase , mechanical engineering , biochemistry , chemistry , physics , optics , engineering , enzyme

The association between hemorrhagic stroke and use of nonsteroidal anti-inflammatory drugs (NSAIDs) is not well established. We conducted a systematic review and meta-analysis of observation studies to further characterize this possible association.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research